BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 35380569)

  • 1. Glycomimetic ligands block the interaction of SARS-CoV-2 spike protein with C-type lectin co-receptors.
    Pollastri S; Delaunay C; Thépaut M; Fieschi F; Bernardi A
    Chem Commun (Camb); 2022 Apr; 58(33):5136-5139. PubMed ID: 35380569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DC/L-SIGN recognition of spike glycoprotein promotes SARS-CoV-2 trans-infection and can be inhibited by a glycomimetic antagonist.
    Thépaut M; Luczkowiak J; Vivès C; Labiod N; Bally I; Lasala F; Grimoire Y; Fenel D; Sattin S; Thielens N; Schoehn G; Bernardi A; Delgado R; Fieschi F
    PLoS Pathog; 2021 May; 17(5):e1009576. PubMed ID: 34015061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sweet Drugs for Bad Bugs: A Glycomimetic Strategy against the DC-SIGN-Mediated Dissemination of SARS-CoV-2.
    Cramer J; Lakkaichi A; Aliu B; Jakob RP; Klein S; Cattaneo I; Jiang X; Rabbani S; Schwardt O; Zimmer G; Ciancaglini M; Abreu Mota T; Maier T; Ernst B
    J Am Chem Soc; 2021 Oct; 143(42):17465-17478. PubMed ID: 34652144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human surfactant protein D facilitates SARS-CoV-2 pseudotype binding and entry in DC-SIGN expressing cells, and downregulates spike protein induced inflammation.
    Beirag N; Kumar C; Madan T; Shamji MH; Bulla R; Mitchell D; Murugaiah V; Neto MM; Temperton N; Idicula-Thomas S; Varghese PM; Kishore U
    Front Immunol; 2022; 13():960733. PubMed ID: 35967323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The S1 spike protein of SARS-CoV-2 upregulates the ERK/MAPK signaling pathway in DC-SIGN-expressing THP-1 cells.
    Johnson EL; Ohkawa Y; Kanto N; Fujinawa R; Kuribara T; Miyoshi E; Taniguchi N
    Cell Stress Chaperones; 2024 Apr; 29(2):227-234. PubMed ID: 38453000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. L-SIGN is a receptor on liver sinusoidal endothelial cells for SARS-CoV-2 virus.
    Kondo Y; Larabee JL; Gao L; Shi H; Shao B; Hoover CM; McDaniel JM; Ho YC; Silasi-Mansat R; Archer-Hartmann SA; Azadi P; Srinivasan RS; Rezaie AR; Borczuk A; Laurence JC; Lupu F; Ahamed J; McEver RP; Papin JF; Yu Z; Xia L
    JCI Insight; 2021 Jul; 6(14):. PubMed ID: 34291736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SARS-CoV-2 exacerbates proinflammatory responses in myeloid cells through C-type lectin receptors and Tweety family member 2.
    Lu Q; Liu J; Zhao S; Gomez Castro MF; Laurent-Rolle M; Dong J; Ran X; Damani-Yokota P; Tang H; Karakousi T; Son J; Kaczmarek ME; Zhang Z; Yeung ST; McCune BT; Chen RE; Tang F; Ren X; Chen X; Hsu JCC; Teplova M; Huang B; Deng H; Long Z; Mudianto T; Jin S; Lin P; Du J; Zang R; Su TT; Herrera A; Zhou M; Yan R; Cui J; Zhu J; Zhou Q; Wang T; Ma J; Koralov SB; Zhang Z; Aifantis I; Segal LN; Diamond MS; Khanna KM; Stapleford KA; Cresswell P; Liu Y; Ding S; Xie Q; Wang J
    Immunity; 2021 Jun; 54(6):1304-1319.e9. PubMed ID: 34048708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C
    Patino-Alonso J; Cabrera-González J; Merino J; Nieto-Ortiz G; Lasala F; Katati J; da Cruz CHB; Monnappa AK; Mateos-Gil P; Canales Á; López-Montero I; Illescas BM; Delgado R; Martín N
    Small; 2024 May; 20(19):e2307045. PubMed ID: 38100142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lectins enhance SARS-CoV-2 infection and influence neutralizing antibodies.
    Lempp FA; Soriaga LB; Montiel-Ruiz M; Benigni F; Noack J; Park YJ; Bianchi S; Walls AC; Bowen JE; Zhou J; Kaiser H; Joshi A; Agostini M; Meury M; Dellota E; Jaconi S; Cameroni E; Martinez-Picado J; Vergara-Alert J; Izquierdo-Useros N; Virgin HW; Lanzavecchia A; Veesler D; Purcell LA; Telenti A; Corti D
    Nature; 2021 Oct; 598(7880):342-347. PubMed ID: 34464958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure of a glycomimetic ligand in the carbohydrate recognition domain of C-type lectin DC-SIGN. Structural requirements for selectivity and ligand design.
    Thépaut M; Guzzi C; Sutkeviciute I; Sattin S; Ribeiro-Viana R; Varga N; Chabrol E; Rojo J; Bernardi A; Angulo J; Nieto PM; Fieschi F
    J Am Chem Soc; 2013 Feb; 135(7):2518-29. PubMed ID: 23360500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pineapple Lectin AcmJRL Binds SARS-CoV-2 Spike Protein in a Carbohydrate-Dependent Fashion.
    Meiers J; Dastbaz J; Adam S; Rasheed S; Kirsch SH; Meiser P; Gross P; Müller R; Titz A
    Chembiochem; 2023 Feb; 24(3):e202200463. PubMed ID: 36420784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Antiviral Activity of the Lectin Griffithsin against SARS-CoV-2 Is Enhanced by the Presence of Structural Proteins.
    Bains A; Fischer K; Guan W; LiWang PJ
    Viruses; 2023 Dec; 15(12):. PubMed ID: 38140693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single-Molecule Analysis of SARS-CoV-2 Binding to C-Type Lectin Receptors.
    Simpson JD; Ray A; Marcon C; Dos Santos Natividade R; Dorrazehi GM; Durlet K; Koehler M; Alsteens D
    Nano Lett; 2023 Feb; 23(4):1496-1504. PubMed ID: 36758952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Noncarbohydrate glycomimetics and glycoprotein surrogates as DC-SIGN antagonists and agonists.
    Prost LR; Grim JC; Tonelli M; Kiessling LL
    ACS Chem Biol; 2012 Sep; 7(9):1603-8. PubMed ID: 22747463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural Characterization of N-Linked Glycans in the Receptor Binding Domain of the SARS-CoV-2 Spike Protein and their Interactions with Human Lectins.
    Lenza MP; Oyenarte I; Diercks T; Quintana JI; Gimeno A; Coelho H; Diniz A; Peccati F; Delgado S; Bosch A; Valle M; Millet O; Abrescia NGA; Palazón A; Marcelo F; Jiménez-Osés G; Jiménez-Barbero J; Ardá A; Ereño-Orbea J
    Angew Chem Int Ed Engl; 2020 Dec; 59(52):23763-23771. PubMed ID: 32915505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gold manno-glyconanoparticles: multivalent systems to block HIV-1 gp120 binding to the lectin DC-SIGN.
    Martínez-Avila O; Hijazi K; Marradi M; Clavel C; Campion C; Kelly C; Penadés S
    Chemistry; 2009 Sep; 15(38):9874-88. PubMed ID: 19681073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combating DC-SIGN-mediated SARS-CoV-2 dissemination by glycan-mimicking polymers.
    Cramer J; Jiang X; Aliu B; Ernst B
    Arch Pharm (Weinheim); 2024 Apr; 357(4):e2300396. PubMed ID: 38086006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Use of Lectins as Tools to Combat SARS-CoV-2.
    Martinez D; Amaral D; Markovitz D; Pinto L
    Curr Pharm Des; 2021; 27(41):4212-4222. PubMed ID: 34459375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human Basigin (CD147) Does Not Directly Interact with SARS-CoV-2 Spike Glycoprotein.
    Ragotte RJ; Pulido D; Donnellan FR; Hill ML; Gorini G; Davies H; Brun J; McHugh K; King LDW; Skinner K; Miura K; Long CA; Zitzmann N; Draper SJ
    mSphere; 2021 Aug; 6(4):e0064721. PubMed ID: 34378982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subtle Influence of ACE2 Glycan Processing on SARS-CoV-2 Recognition.
    Allen JD; Watanabe Y; Chawla H; Newby ML; Crispin M
    J Mol Biol; 2021 Feb; 433(4):166762. PubMed ID: 33340519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.